Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|July 21, 2020
[AN EXPERIENCE OF PARTIAL NEPHRECTOMY IN A PATIENT WITH VON WILLEBRAND DISEASE]Suguru Ito, Atsushi Yamagishi, Masayuki Kurokawa, et al.
Clinical Genitourinary Cancer|May 30, 2020
Sunitinib Versus Sorafenib as Initial Targeted Therapy for mCC-RCC With Favorable/Intermediate Risk: Multicenter Randomized Trial CROSS-J-RCCYoshihiko Tomita, Sei Naito, Naoto Sassa, et al.
Oncology Letters|March 19, 2019
Expression of total and phospho 4EBP1 in metastatic and non-metastatic renal cell carcinomaSei Naito, Osamu Ichiyanagi, Hiromi Ito, et al.
International Journal of Clinical Oncology|June 30, 2021
Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy eraSei Naito, Tomoyuki Kato, Kazuyuki Numakura, et al.
Cancer Science|July 18, 2022
Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumabShuhei Takahashi, Shintaro Narita, Nobuhiro Fujiyama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 2, 2024
Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in JapanYuki Kita, Hikari Otsuka, Katsuhiro Ito, et al.
European Urology|January 13, 2009
Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patientsSei Naito, Naoki Yamamoto, Tatsuya Takayama, et al.
Biomedicines|November 25, 2023
Intracellular Major Histocompatibility Complex Class II and C-X-C Motif Chemokine Ligand 10-Expressing Neutrophils Indicate the State of Anti-Tumor Activity Induced by Bacillus Calmette-GuérinYuji Takeda, Tomoyuki Kato, Saima Sabrina, et al.
Cancer Science|December 7, 2020
Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumabTakashi Kobayashi, Katsuhiro Ito, Takahiro Kojima, et al.
Urologic Oncology|August 29, 2021
Impact of prior intravesical bacillus Calmette-Guerin therapy on the effectiveness of pembrolizumab for patients with metastatic urothelial carcinomaRikiya Taoka, Takashi Kobayashi, Yu Hidaka, et al.
Pageof 10